After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. DDW’s Diana Spencer unpacks the Q3 figures and annual predictions from the BioIndustry Association1. While 2021 was the highest year on record for… Read More
Australia’s drug discovery industry shows promise and innovation, as well as business opportunities. DDW’s Megan Thomas takes a look at some of the reasons why we should be keeping an interested eye on the developments coming out of this country. The Sector Snapshot 2022: Expansion is continuous … Read More
DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research. Japan continues to be one of the largest pharmaceutical markets in the world,… Read More
Listen to this article on the DDW podcast: Dr Stephan Emmerth and Paul Eschmann, Basel Area Business & Innovation, explain the benefits of being based in Basel – the talent pool, global players, academic institutions and investors, for example. Companies specialising in oncology R&D… Read More
As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? Lu Rahman highlights some of the key players. The European drug discovery sector is buoyant. Valued at $14.8 billion… Read More
Listen to this article on the DDW podcast: As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? Lu Rahman highlights some of the key players. The European drug discovery sector is buoyant. Valued… Read More
Listen to this article on the DDW Podcast: Lu Rahman takes a snapshot of the US biotech market and how its successes are having a positive effect on its UK counterpart. These are uncertain times for global markets. As the world attempts to recover from the Covid-19 pandemic, the… Read More
DDW Deputy Editor Reece Armstrong recently attended the Invest in Toulouse Virtual Round Table to find out how the city is establishing itself as a place of exciting research in the healthcare sectors. Hosted by Jean-Claude Dardelet, the city’s Deputy Mayor, the roundtable examined how Toulouse… Read More
Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW’s Market Report, Dr Henry Li, CSO, Crown Bioscience examines cycles of innovation in the Chinese… Read More
A group of researchers at Qatar Foundation and Hamad Medical Corporation has released a study that highlights a total of 60 disease-causing genetic variants linked with cancer, heart diseases, high cholesterol level and other diseases, with cancer-associated variants being the most frequent – which is consistent with the high… Read More
Examining the role of the pharmaceutical industry in alleviating challenges is helpful to understand how people are benefiting from innovative medicines. This report examines the impact of the pharmaceutical industry in nine Latin American countries (Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama, and Peru) by analysing its impact… Read More
Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW’s Market Report, DDW Editor Lu Rahman explores the Chinese pharmaceutical… Read More
New research, involving 200 professionals in senior roles spanning pharmacovigilance (PV), Drug Safety and Product Safety departments, has found that quality has overtaken cost as a priority in plans for automating adverse event (AE) reporting. John Price, life sciences industry consultant and partner of Arriello, which commissioned this latest research, reports on the findings. … Read More
Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW’s Market Report, Sy Chyi Yeoh, Director of Business Development at global regulatory service provider ELC Group, explains why the biotech sector in China is worth watching and offers advice for those… Read More
The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients. The potential for AI to address these pain points has drawn significant attention from investors and players in the pharmaceutical industry. … Read More
A report by Fact.MR reveals that the global antibacterial drugs market is projected to grow at a modest CAGR of 2.6% during the forecast period (2021-2031), expected to reach a value of US$62 billion. In the short run, the market is poised to expand at a CAGR of 1.5%… Read More
